Artificial Intelligence to Measure Adherence to Oral Medication
NCT ID: NCT04046497
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
200 participants
INTERVENTIONAL
2020-11-20
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
NCT00406718
Improving Antipsychotic Adherence Among Patients With Serious Mental Illness
NCT00057135
Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes
NCT04004364
An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder
NCT00861003
Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia
NCT01555697
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Smartphone App
artificial intelligence (AI) smartphone app to provide support for medication adherence
Smartphone App
artificial intelligence (AI) smartphone app to provide support for medication adherence
Usual Care
Usual care provided at CSC clinic
Usual Care
Usual Care provided by CSC clinic
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Smartphone App
artificial intelligence (AI) smartphone app to provide support for medication adherence
Usual Care
Usual Care provided by CSC clinic
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Prescribed an oral antipsychotic
Exclusion Criteria
15 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Northwell Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Citrus Health
Hialeah, Florida, United States
InterAct
Grand Rapids, Michigan, United States
InterAct of Michigan
Kalamazoo, Michigan, United States
Red Rock
Oklahoma City, Oklahoma, United States
Family and Children's Services
Tulsa, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Cristina Gonzalez, MS
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jacob Gonzalez
Role: primary
Dana Schrader
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-0307-ZHH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.